NMPA Approval

Lanreotide acetate sustained-release injection (a pre-filled syringe)

Approval Number

国药准字HJ20190057

Registration Date

May 22, 2024

Previous Approval Numbers

H20190057

Drug Information

Generic Name

醋酸兰瑞肽缓释注射液(预充式)

Dosage Form

注射剂

Strength

60mg (以C₅₄H₆₉N₁₁O₁₀S₂计)

Drug Type

化学药品

Registration Date

May 22, 2024

Expiry Date

May 21, 2029

Company Address

65, quai Georges Gorse，92100 BOULOGNE-BILLANCOURT- FRANCE

Company Address

Parc d'Activités du Plateau de Signes, Chemin Départemental n°402, 83870 SIGNES-France

Empowering clinical research with data-driven insights and AI-powered tools.